Severity Reduced With Mpox Reinfection, Postvaccination Infection

MONDAY, Sept. 11, 2023 -- The clinical features and outcomes of mpox reinfection and infection postvaccination are less clinically severe than initial infection, according to a global case series published online Sept. 4 in The Lancet Infectious...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals